Reference number : 276-2020-2021-Q2-00117, amendment number : , agreement type : C, recipient legal name : Soricimed Biopharma Inc.|Soricimed Biopharma Inc., recipient country : CA, recipient province : NB, recipient city : Moncton|Moncton, recipient postal code : E1C 4W7, program name english : REGI - Business Scale-up and Productivity, program name french : CERI - Expansion/productivité des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 216770, agreement title french : 216770, agreement number : 216770, agreement value : 500000.0, agreement start date : 2020-07-17, agreement end date : 2020-12-31, description english : Provide assistance to mitigate impacts of Covid-19, description french : Fournir une assistance pour atténuer les impacts de la Covid-19, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique